NAOMI PARK: Open Payments
NPI 1710293675 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 50 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $386 |
| Alkermes, Inc. | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Corium, LLC | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: VRAYLAR, LYBALVI, REXULTI, FANAPT, Auvelity, Azstarys, AUSTEDO XR, Jornay PM.
Industry payments across AZ — which companies pay providers there.
